A Cluster RCT Of The Impact Of A Community-based Hygiene And Sanitation Programme On Infection With Intestinal Parasites Following Mass Albendazole Chemotherapy In Timor-Leste
Funder
National Health and Medical Research Council
Funding Amount
$1,178,136.00
Summary
Intestinal parasites cause anaemia, stunting, wasting and poor mental development in childhood, and are related to poverty and poor hygiene. Treatment with antiparasitic drugs cures infections in human hosts, but does not prevent rapid re-infection when people contact a parasite-contaminated environment. We will quantify the impact of a hygiene and sanitation programme that reduces environmental contamination in communities that receive mass treatment with the antiparasitic drug albendazole.
Uptake, Sustainability And Impact Of Scaling Up Point-of-care Testing For Sexually Transmissible Infections In Remote And Regional Aboriginal Communities
Funder
National Health and Medical Research Council
Funding Amount
$1,461,788.00
Summary
Aboriginal youth experience unacceptably high rates of curable sexually transmissible infections (STI). Coverage of testing and treatment is insufficient for disease control but could be enhanced via point-of-care (POC) testing. We have been trialling a highly accurate STI/POC diagnostic in the TTANGO (Test, Treat ANd GO) trial. The TTANGO2 partnership will assess the long-term uptake, sustainability and impact of POC testing in 20 Aboriginal health services in regional/remote WA over 5 years.
An Evidence Based Framework For Establishing Public Health Microbial Genomics In Australia
Funder
National Health and Medical Research Council
Funding Amount
$1,413,093.00
Summary
Microbial genomics is a powerful laboratory tool to characterise human pathogens at the highest level, allowing greater understanding of the source and spread of pathogens that infect humans. In this project, through close links with the Victorian Government, we will determine how this exciting new technology can best be applied to prevent the spread of high risk human pathogens, and inform public health action.
Should Australia Introduce A National Chlamydia Testing Program? Evaluation Of A Randomised Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$518,510.00
Summary
Chlamydia is a very common sexually transmissible infection that can lead to infertility in women. About 4% of young adults have it, yet most are unaware they have it. Chlamydia is easy to diagnose and treat, but it is not known whether annual testing can reduce its spread. Over1 million tests are conducted each year in general practice, costing the government $30 million. This evaluation of a well-established trial of chlamydia testing in young adults will resolve the debate of whether annual t ....Chlamydia is a very common sexually transmissible infection that can lead to infertility in women. About 4% of young adults have it, yet most are unaware they have it. Chlamydia is easy to diagnose and treat, but it is not known whether annual testing can reduce its spread. Over1 million tests are conducted each year in general practice, costing the government $30 million. This evaluation of a well-established trial of chlamydia testing in young adults will resolve the debate of whether annual testing works and is a good use of money.Read moreRead less
Developing And Implementing Systems To Optimise Treatment, Care And Support Among People Diagnosed With HIV
Funder
National Health and Medical Research Council
Funding Amount
$1,021,439.00
Summary
Immediate treatment of people diagnosed with HIV infection has become a key public health intervention, based on recent evidence confirming treatment suppresses the virus to undetectable levels, and effectively eliminates the risk of transmission to sexual partners. Our partnership will identify and address barriers to accessing specialist HIV care and starting treatment among people recently diagnosed with HIV, and will contribute to Australia’s goal of ending HIV transmission by 2020.
The HIV Prevention Revolution: Measuring Outcomes And Maximising Effectiveness
Funder
National Health and Medical Research Council
Funding Amount
$1,081,723.00
Summary
There have been extra-ordinary recent biomedical advances in HIV prevention. These present an opportunity to turn the HIV epidemic around. We will undertake implementation research to optimise the impact of the new tools at the population level. NSW has a detailed HIV strategy with explicit targets for reduction of HIV transmission over the period 2012 to 2020. Our research will guide optimum program delivery to drive new HIV infections down in Australia and other high income settings.
HealthMap: A Cluster Randomised Trial Of Interactive Self-care Plans To Prevent And Manage Chronic Conditions By People Living With HIV
Funder
National Health and Medical Research Council
Funding Amount
$1,592,697.00
Summary
Australia’s ageing population is increasingly at risk of chronic diseases such as heart disease and diabetes. For Australians who are living with HIV, these diseases are more common and often occur at an earlier age. This project will evaluate online programs that help people living with HIV work with their healthcare providers to identify individual health goals and reduce their risk of chronic disease. This project will provide important information for Australians at risk of developing these ....Australia’s ageing population is increasingly at risk of chronic diseases such as heart disease and diabetes. For Australians who are living with HIV, these diseases are more common and often occur at an earlier age. This project will evaluate online programs that help people living with HIV work with their healthcare providers to identify individual health goals and reduce their risk of chronic disease. This project will provide important information for Australians at risk of developing these diseases.Read moreRead less